Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.

This study assessed the risk of skin cancer following transplantation of 4 types of solid organs, and the risk of skin cancer in patients with chronic diseases that lead to organ transplantations. A population-based cohort of 5279 Danish patients who underwent heart, lung, renal and liver transplantation, and 77,782 patients with chronic heart, lung, renal and liver diseases during 1977-2006 were included in the study. Linkage to the Danish Cancer Registry allowed complete follow-up for basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated. The SIR for squamous cell carcinoma was highest among heart (SIR = 113; 95% CI: 74-166), then renal (SIR = 81; 95% CI: 68-96), lung (SIR = 65; 95% CI: 28-128) and liver (SIR = 60; 95% CI: 27-113) recipients. SIR for squamous cell carcinoma was 4.8 (95% CI: 2.2-9.0) among renal failure patients, but not greatly elevated among patients with the other chronic diseases studied. Organ transplantation is a risk factor for squamous cell carcinoma, with immunosuppressive treatments being the most likely explanation for the association.

[1]  D. Terhorst,et al.  Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure , 2009, The British journal of dermatology.

[2]  D. Hanto,et al.  Post‐transplant de novo malignancies in renal transplant recipients: the past and present , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  P. Karran,et al.  Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage , 2005, Science.

[4]  B. Kasiske,et al.  Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  R. Stern,et al.  Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study , 2001, The Lancet.

[6]  P. Macdonald,et al.  Aggressive cutaneous malignancies following cardiothoracic transplantation , 1999, Cancer.

[7]  M. Lagman,et al.  Cyclosporine induces cancer progression by a cell-autonomous mechanism , 1999, Nature.

[8]  S Hansen,et al.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.

[9]  H. Storm,et al.  The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.

[10]  M. Raftery,et al.  Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients , 1997, The Lancet.

[11]  B. O'Sullivan,et al.  The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. , 1996, Transplantation.

[12]  Eero Pukkala,et al.  Cancer risk after renal transplantation in the nordic countries, 1964–1986 , 1995, International journal of cancer.

[13]  J. Vandenbroucke,et al.  Incidence of skin cancer after renal transplantation in The Netherlands. , 1990, Transplantation.

[14]  R. Doll,et al.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. , 1979, British medical journal.

[15]  R. Hoover,et al.  Risk of cancer in renal-transplant recipients. , 1973, Lancet.

[16]  J. Wauters,et al.  Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[17]  P. Macdonald,et al.  Skin cancer in Australian heart transplant recipients. , 1999, Journal of the American Academy of Dermatology.

[18]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.